Portal Hypertension Bleeding in Cirrhosis
AASLD develops evidence-based practice guidelines and practice guidances which are updated regularly by a multi-disciplinary panel of experts, including hepatologists, and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.
Practice Guidance
AASLD Practice Guidance on Risk Stratification and Management of Portal Hypertension and Varices in Cirrhosis
This guidance provides a data-supported approach to risk stratification, diagnosis, and management of patients with cirrhosis and portal hypertension (PH). Included guidance statements are based on the following: (1) review of the recent literature using PubMed, giving more weight to large, well-designed, prospective trials and well-performed meta-analyses; (2) expert opinion from consensus conferences; and (3) the authors’ years of experience caring for patients with cirrhosis and varices. The expanded role for non-invasive liver diagnosis assessments (NILDAs) in identifying clinically significant portal hypertension is highlighted, and an evolving pragmatic paradigm utilizing NILDA in day-to-day clinical practice is promulgated.
Quality Measures on Cirrhosis
AASLD develops quality measures to help its members measure or quantify healthcare processes and outcomes that are associated with the ability to provide high-quality health care.